Recent perspectives on the delivery of biologics to back of the eye
Introduction: Biologics are generally macromolecules, large in size with poor stability in
biological environments. Delivery of biologics to tissues at the back of the eye remains a …
biological environments. Delivery of biologics to tissues at the back of the eye remains a …
Recent perspectives on the delivery of biologics to back of the eye.
M Joseph, HM Trinh, K Cholkar, D Pal… - Expert Opinion on Drug …, 2016 - europepmc.org
Introduction—Biologics are generally macromolecules, large in size with poor stability in
biological environments. Delivery of biologics to tissues at the back of the eye remains a …
biological environments. Delivery of biologics to tissues at the back of the eye remains a …
Recent perspectives on the delivery of biologics to back of the eye
M Joseph, HM Trinh, K Cholkar… - Expert opinion on …, 2017 - pubmed.ncbi.nlm.nih.gov
Biologics are generally macromolecules, large in size with poor stability in biological
environments. Delivery of biologics to tissues at the back of the eye remains a challenge. To …
environments. Delivery of biologics to tissues at the back of the eye remains a challenge. To …
[HTML][HTML] Recent perspectives on the delivery of biologics to back of the eye
M Joseph, HM Trinh, K Cholkar, D Pal… - Expert opinion on drug …, 2017 - ncbi.nlm.nih.gov
Introduction—Biologics are generally macromolecules, large in size with poor stability in
biological environments. Delivery of biologics to tissues at the back of the eye remains a …
biological environments. Delivery of biologics to tissues at the back of the eye remains a …
Recent perspectives on the delivery of biologics to back of the eye.
M Joseph, HM Trinh, K Cholkar, D Pal… - Expert Opinion on Drug …, 2016 - europepmc.org
Biologics are generally macromolecules, large in size with poor stability in biological
environments. Delivery of biologics to tissues at the back of the eye remains a challenge. To …
environments. Delivery of biologics to tissues at the back of the eye remains a challenge. To …